SCHEMBL310450

SCHEMBL310450

CC(C)CO[SiH](C)OCC(C)C

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9722154 0.85
SCHEMBL5686402 0.80
SCHEMBL26676521 0.79
SCHEMBL309139 0.76 ALDH1A1 (0.36) ALDH1A1
SCHEMBL27521836 0.75 TSHR (0.38) ALDH1A1
SCHEMBL10357935 0.73
SCHEMBL9633974 0.71 ALDH1A1 (0.33) ALDH1A1
SCHEMBL27752405 0.71
SCHEMBL5833900 0.71 ALDH1A1 (0.33) ALDH1A1
SCHEMBL5834549 0.69 ALDH1A1 (0.32) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112724405-B Curing agent mixture 赢创运营有限公司 2024-01-30 CN disclosed
CN-115678542-A Quaternary nanostructure based on bright silver 纳米系统公司 2023-02-03 CN disclosed
CN-113840895-B Quaternary nanostructure based on bright silver 纳米系统公司 2022-11-15 CN disclosed
CN-112724405-A Curing agent mixture 赢创运营有限公司 2021-04-30 CN disclosed
CN-110885427-A Tin-free catalysis of silane-functional polyurethane crosslinkers 赢创运营有限公司 2020-03-17 CN disclosed
US-8093419-B2 Method of producing organosilicon compound JSR CORPORATION (JP) 2012-01-10 US disclosed
US-20100261925-A1 METHOD FOR PRODUCING SILICON COMPOUND JSR CORPORATION (JP) 2010-10-14 US disclosed
US-20090299086-A1 METHOD OF PRODUCING ORGANOSILICON COMPOUND JSR CORPORATION (JP) 2009-12-03 US disclosed
US-7572303-B2 A symmetrical dialkyl carbonate, a metal, borong, silicon, or group 7 compound, a hydrogen or hydrocarbon-based fuel, an oxidizer, and a metallic cocatalyst; minimized hydrolysis; improved combustion and storage stability OCTANE INTERNATIONAL, LTD. (US) 2009-08-11 US disclosed
EP-0954558-B1 FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY ORR WILLIAM C (US) 2006-06-14 EP disclosed
US-6402961-B1 HYDROSILATION OF SILANE AND ALLYL GLYCIDYL ETHER IN THE PRESENCE OF PLATINUM, PALLADIUM, RHENIUM, OR IRIDIUM TO FORM EPOXYSILANOLS WITHOUT CYCLIZATION DEGUSSA AG (DE) 2002-06-11 US disclosed
EP-0885895-B1 N-[omega-(methyl),omega-(silyl)]alkyl-N-organocarboxamide, their oligomers and polycondensates, process for their preparation and their use DEGUSSA (DE) 2001-11-07 EP disclosed
EP-1070721-A2 Process for preparing epoxysilanes Degussa-Hüls Aktiengesellschaft (DE) 2001-01-24 EP disclosed
EP-1051461-A2 FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE ORR, William C. (US) 2000-11-15 EP disclosed
US-6020448-A N-[ω-(methyl),ω-(silyl)] alkyl-N-organocarboxamides, oligomeric and polycondensed Si-containing compounds thereof, processes for their preparation, and their use HUELS AKTIENGESELLSCHAFT (DE) 2000-02-01 US disclosed
WO-1999066009-A2 FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE ORR WILLIAM C (US) 1999-12-23 WO disclosed
EP-0954558-A1 FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY ORR, William C. (US) 1999-11-10 EP disclosed
EP-0885895-A2 N-[omega-(methyl),omega-(silyl)]alkyl-N-organocarboxamide, their oligomers and polycondensates, process for their preparation and their use HÜLS AKTIENGESELLSCHAFT (DE) 1998-12-23 EP disclosed
WO-1998026028-A1 FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY ORR WILLIAM C (US) 1998-06-18 WO disclosed
US-5068382-A PROCESS FOR THE PRODUCTION OF ORGANOSILICON COMPOUNDS HUELS AKTIENGESELLSCHAFT (DE) 1991-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261925-A1 METHOD FOR PRODUCING SILICON COMPOUND GMNN, GEMIN5, SEPTIN7 ALDH1A1 3835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.